ALVO vs ELAN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVO is a Hold and ELAN is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALVO’s FA Score shows that 1 FA rating(s) are green whileELAN’s FA Score has 0 green FA rating(s).
- ALVO’s FA Score: 1 green, 4 red.
- ELAN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALVO’s TA Score shows that 5 TA indicator(s) are bullish while ELAN’s TA Score has 4 bullish TA indicator(s).
- ALVO’s TA Score: 5 bullish, 6 bearish.
- ELAN’s TA Score: 4 bullish, 4 bearish.
Price Growth
ALVO (@Pharmaceuticals: Other) experienced а -5.47% price change this week, while ELAN (@Pharmaceuticals: Other) price change was -2.04% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.14%. For the same industry, the average monthly price growth was +77.04%, and the average quarterly price growth was +50.35%.
Reported Earning Dates
ALVO is expected to report earnings on May 16, 2025.
ELAN is expected to report earnings on May 13, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (-1.14% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| ALVO | ELAN | ALVO / ELAN | |
| Capitalization | 3.48B | 7.87B | 44% |
| EBITDA | -493.67M | -224M | 220% |
| Gain YTD | -7.181 | -9.001 | 80% |
| P/E Ratio | 57.47 | N/A | - |
| Revenue | 91.4M | 4.42B | 2% |
| Total Cash | 11.2M | 352M | 3% |
| Total Debt | 1.08B | 5.77B | 19% |
ELAN | ||
|---|---|---|
OUTLOOK RATING 1..100 | 59 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 57 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 85 | |
PRICE GROWTH RATING 1..100 | 83 | |
P/E GROWTH RATING 1..100 | 81 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ALVO | ELAN | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 67% | N/A |
| Stochastic ODDS (%) | 3 days ago 56% | 3 days ago 62% |
| Momentum ODDS (%) | 3 days ago 48% | 3 days ago 77% |
| MACD ODDS (%) | 3 days ago 55% | 3 days ago 62% |
| TrendWeek ODDS (%) | 3 days ago 57% | 3 days ago 75% |
| TrendMonth ODDS (%) | 3 days ago 61% | 3 days ago 73% |
| Advances ODDS (%) | 10 days ago 64% | 26 days ago 63% |
| Declines ODDS (%) | 4 days ago 64% | 3 days ago 74% |
| BollingerBands ODDS (%) | 3 days ago 72% | 3 days ago 89% |
| Aroon ODDS (%) | 3 days ago 62% | 3 days ago 73% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| REEAX | 13.52 | -0.02 | -0.15% |
| RBC Emerging Markets Equity A | |||
| IEYYX | 9.12 | -0.10 | -1.08% |
| Macquarie Climate Solutions Y | |||
| GSBGX | 23.11 | -0.38 | -1.62% |
| GMO Small Cap Quality Fund Class VI | |||
| ICAFX | 59.37 | -1.12 | -1.85% |
| American Funds Invmt Co of Amer F2 | |||
| FGADX | 23.34 | -0.80 | -3.31% |
| Franklin Gold and Precious Metals Adv | |||
ALVO and
Correlation & Price change
A.I.dvisor tells us that ALVO and AKAN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and AKAN's prices will move in lockstep.
| Ticker / NAME | Correlation To ALVO | 1D Price Change % | ||
|---|---|---|---|---|
| ALVO | 100% | +4.96% | ||
| AKAN - ALVO | 24% Poorly correlated | +1.74% | ||
| CURLF - ALVO | 21% Poorly correlated | -0.70% | ||
| CRON - ALVO | 20% Poorly correlated | +1.55% | ||
| ELAN - ALVO | 20% Poorly correlated | -0.99% | ||
| PRGO - ALVO | 20% Poorly correlated | +0.40% | ||
More | ||||
ELAN and
Correlation & Price change
A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with SNDL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then SNDL could also see price increases.
| Ticker / NAME | Correlation To ELAN | 1D Price Change % | ||
|---|---|---|---|---|
| ELAN | 100% | -0.99% | ||
| SNDL - ELAN | 39% Loosely correlated | +0.57% | ||
| ACET - ELAN | 33% Poorly correlated | -2.66% | ||
| PCRX - ELAN | 32% Poorly correlated | -2.25% | ||
| VTRS - ELAN | 29% Poorly correlated | +1.72% | ||
| TAK - ELAN | 27% Poorly correlated | +1.44% | ||
More | ||||